Henry Schein
Henry Schein, Inc., a leading global provider of healthcare products and services, is headquartered in the United States. Founded in 1932, the company has established a strong presence in the dental, medical, and veterinary sectors, serving healthcare professionals across North America, Europe, and Asia. With a diverse portfolio that includes dental supplies, medical equipment, and practice management software, Henry Schein is renowned for its commitment to innovation and customer service. The company has achieved significant milestones, including its recognition as one of the Fortune 500 and its consistent ranking among the top healthcare distributors globally. Henry Schein's unique approach combines comprehensive product offerings with tailored solutions, making it a trusted partner for healthcare providers seeking to enhance patient care and operational efficiency.
DitchCarbon Score
How does Henry Schein's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Henry Schein's score of 57 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Henry Schein's reported carbon emissions
In 2023, Henry Schein reported total greenhouse gas emissions of approximately 58304000 kg CO2e from Scope 1, which includes mobile combustion, and 776259000 kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions across its entire value chain by 2050. For near-term targets, Henry Schein plans to reduce absolute Scope 1 emissions by 42% by 2030 from a 2022 baseline. Additionally, the company is committed to sourcing 100% renewable electricity by 2030, up from 0% in 2022. They also aim to reduce Scope 3 emissions by 51.6% per million USD value added by 2030. Long-term goals include a 90% reduction in absolute Scope 1 emissions by 2050 and a 97% reduction in Scope 3 emissions per million USD value added by the same year. These targets align with the Science Based Targets initiative (SBTi) and reflect Henry Schein's commitment to addressing climate change and reducing its carbon footprint in the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 48,846,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Henry Schein is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
